201 related articles for article (PubMed ID: 22684556)
1. Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Cheng Z; Song W; Zhou L; Tao Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Jun; 32(3):346-352. PubMed ID: 22684556
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
[TBL] [Abstract][Full Text] [Related]
3. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
Wu S; Cheng Z; Yu L; Song W; Tao Y
Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
[TBL] [Abstract][Full Text] [Related]
4. Expression of maspin in non-small-cell lung cancer: correlation with clinical features.
Takanami I; Abiko T; Koizumi S
Clin Lung Cancer; 2008 Nov; 9(6):361-6. PubMed ID: 19073519
[TBL] [Abstract][Full Text] [Related]
5. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry.
Ci H; Xu Z; Xu J; Wang Y; Wu S
Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593
[TBL] [Abstract][Full Text] [Related]
6. Maspin expression and its clinical significance in non-small cell lung cancer.
Nakagawa M; Katakura H; Adachi M; Takenaka K; Yanagihara K; Otake Y; Wada H; Tanaka F
Ann Surg Oncol; 2006 Nov; 13(11):1517-23. PubMed ID: 17009165
[TBL] [Abstract][Full Text] [Related]
7. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
9. [Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density].
Han ZG; Yu TT; Shan L
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):605-8. PubMed ID: 23158995
[TBL] [Abstract][Full Text] [Related]
10. Maspin expression is a favorable prognostic factor in non-small cell lung cancer.
Berardi R; Santinelli A; Onofri A; Brunelli A; Pierantoni C; Pisa E; Pagliacci A; Stramazzotti D; Zuccatosta L; Mazzanti P; Sabbatini A; Gasparini S; Bearzi I; Cascinu S
Anal Quant Cytol Histol; 2012 Apr; 34(2):72-8. PubMed ID: 22611762
[TBL] [Abstract][Full Text] [Related]
11. Increased NDRG1 expression is associated with advanced T stages and poor vascularization in non-small cell lung cancer.
Fan C; Yu J; Liu Y; Xu H; Wang E
Pathol Oncol Res; 2012 Jul; 18(3):549-56. PubMed ID: 20853080
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
13. Imaging proliferation of ¹⁸F-FLT PET/CT correlated with the expression of microvessel density of tumour tissue in non-small-cell lung cancer.
Yang W; Zhang Y; Fu Z; Sun X; Mu D; Yu J
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1289-96. PubMed ID: 22581165
[TBL] [Abstract][Full Text] [Related]
14. The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.
Wang XF; Liang B; Zeng DX; Lei W; Chen C; Chen YB; Huang JA; Gu N; Zhu YH
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391558
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
16. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
[TBL] [Abstract][Full Text] [Related]
17. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
18. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
[TBL] [Abstract][Full Text] [Related]
19. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
